Molecular Biomarkers of Epileptogenesis

Neurotherapeutics

Volumn 11, Issue 2, 2014, Pages 319-323

  Lukasiuk, Katarzyna ^a   Becker, Albert J ^b  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cerebrospinal fluid; epilepsy; plasma; seizures; traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MICRORNA; MYELIN BASIC PROTEIN; N ACETYLASPARTIC ACID; NEURON SPECIFIC ENOLASE; PROTEIN S100B; TAU PROTEIN; UBIQUITIN THIOLESTERASE;

ANATOMICAL CONCEPTS; BLOOD BRAIN BARRIER; BODY FLUID; BRAIN TISSUE; CEREBROSPINAL FLUID; DNA METHYLATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTOGENESIS; GENOMICS; GLUCOSE METABOLISM; HUMAN; MICROGLIA; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SEIZURE THRESHOLD; TRAUMATIC BRAIN INJURY; TREATMENT RESPONSE; BRAIN INJURIES; STATUS EPILEPTICUS;

BIOLOGICAL MARKERS; BRAIN INJURIES; EPILEPSY; HUMANS; STATUS EPILEPTICUS;

EID: 84899488264     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-014-0261-6     Document Type: Review

References (28)

1. Pitkanen A, Lukasiuk K. Molecular biomarkers of epileptogenesis. Biomark Med 2011;5: 629-633.
2. Engel J, Jr., Pitkanen A, Loeb JA, et al. Epilepsy biomarkers. Epilepsia 2013;54(Suppl. 4): 61-69.
3. Pitkanen A, Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 2011;10: 173-186.
4. Becker AJ, Pitsch J, Sochivko D, et al. Transcriptional upregulation of Cav3. 2 mediates epileptogenesis in the pilocarpine model of epilepsy. J Neurosci 2008;28: 13341-13353.
5. Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001;345: 311-318.
6. Weller M, Stupp R, Hegi ME, et al. Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice. Neuro Oncol 2012;14(Suppl. 4): iv100-108.
7. Holdhoff M, Yovino SG, Boadu O, Grossman SA. Blood-based biomarkers for malignant gliomas. J Neurooncol 2013;113: 345-352.
8. Goffin K, van Paesschen W, Dupont P, van Laere K. Longitudinal microPET imaging of brain glucose metabolism in rat lithium-pilocarpine model of epilepsy. Exp Neurol 2009;217: 205-209.
9. Jupp B, Williams J, Binns D, et al. Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE. Epilepsia 2012;53: 1233-1244.
10. Guo Y, Gao F, Wang S, et al. In vivo mapping of temporospatial changes in glucose utilization in rat brain during epileptogenesis: an 18F-fluorodeoxyglucose-small animal positron emission tomography study. Neuroscience 2009;162: 972-979.
11. Shultz SR, Cardamone L, Liu YR, et al. Can structural or functional changes following traumatic brain injury in the rat predict epileptic outcome? Epilepsia 2013;54: 1240-1250.
12. Filibian M, Frasca A, Maggioni D, Micotti E, Vezzani A, Ravizza T. In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity. Epilepsia 2012;53: 1907-1916.
13. Mao H, Toufexis D, Wang X, Lacreuse A, Wu S. Changes of metabolite profile in kainic acid induced hippocampal injury in rats measured by HRMAS NMR. Exp Brain Res 2007;183: 477-485.
14. Devi PU, Manocha A, Vohora D. Seizures, antiepileptics, antioxidants and oxidative stress: an insight for researchers. Expert Opin Pharmacother 2008;9: 3169-3177.
15. Nehlig A. Hippocampal MRI and other structural biomarkers: experimental approach to epileptogenesis. Biomark Med 2011;5: 585-597.
16. Holtman L, van Vliet EA, Aronica E, Wouters D, Wadman WJ, Gorter JA. Blood plasma inflammation markers during epileptogenesis in post-status epilepticus rat model for temporal lobe epilepsy. Epilepsia 2013;54: 589-595.
17. Dash PK, Zhao J, Hergenroeder G, Moore AN. Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurotherapeutics 2010;7: 100-114.
18. Feala JD, Abdulhameed MD, Yu C, et al. Systems biology approaches for discovering biomarkers for traumatic brain injury. J Neurotrauma 2013;30: 1101-1116.
19. Sjodin MO, Bergquist J, Wetterhall M. Mining ventricular cerebrospinal fluid from patients with traumatic brain injury using hexapeptide ligand libraries to search for trauma biomarkers. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878: 2003-2012.
20. Pitkanen A, Lukasiuk K. Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav 2009;14(Suppl. 1): 16-25.
21. Glushakova OY, Jeromin A, Martinez J, et al. Cerebrospinal fluid protein biomarker panel for assessment of neurotoxicity induced by kainic acid in rats. Toxicol Sci 2012;130: 158-167.
22. Sankar R, Shin DH, Wasterlain CG. Serum neuron-specific enolase is a marker for neuronal damage following status epilepticus in the rat. Epilepsy Res 1997;28: 129-136.
23. DeGiorgio CM, Heck CN, Rabinowicz AL, Gott PS, Smith T, Correale J. Serum neuron-specific enolase in the major subtypes of status epilepticus. Neurology 1999;52: 746-749.
24. Lin YY, Yen SH, Pan JT, Su MS, Wu ZA, Chan SH. Transient elevation in plasma prolactin level in rats with temporal lobe status epilepticus. Neurology 1999;53: 885-887.
25. Tomson T, Lindbom U, Nilsson BY, Svanborg E, Andersson DE. Serum prolactin during status epilepticus. J Neurol Neurosurg Psychiatry 1989;52: 1435-1437.
26. Tang Y, Lu A, Aronow BJ, Sharp FR. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol 2001;50: 699-707.
27. Liu DZ, Tian Y, Ander BP, et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 2010;30: 92-101.
28. Blumcke I, Thom M, Wiestler OD. Ammon's horn sclerosis: a maldevelopmental disorder associated with temporal lobe epilepsy. Brain Pathol 2002;12: 199-211.